2m 2m 2m 2m 2m 2m 2m
AbbVie (ABBV)
NYSE
$297.40+$2.42 (+0.82%)
Price as of Nov 12, 2026 8:20 AM EST- $521.4BMarket Cap
- 30.26%1-Year Change
- Drug Manufacturers - GeneralIndustry
AbbVie (ABBV)
$297.40+$2.42 (+0.82%)
Earnings Score
Valuation | ABBV | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | 0 | ||
Growth | -0 | ||
Low Earnings Volatility | 1 |
Momentum Score
Valuation | ABBV | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | 9.70% | ||
12-Month Momentum | 24.73% | ||
3-Month Risk Adjusted Momentum | 115.14% | ||
12-Month Risk Adjusted Momentum | 100.93% |
True Yield
Valuation | ABBV | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | 2.35% | ||
Net Buyback Yield | 0.33% | ||
Net Debt Paydown Yield | -2.47% |
Financial Health Score
Valuation | ABBV | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 10 |